|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 22805 |
FusionGeneSummary for MTMR3_TSHZ2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MTMR3_TSHZ2 | Fusion gene ID: 22805 | Hgene | Tgene | Gene symbol | MTMR3 | TSHZ2 | Gene ID | 8897 | 128553 |
| Gene name | myotubularin related protein 3 | teashirt zinc finger homeobox 2 | |
| Synonyms | FYVE-DSP1|ZFYVE10 | C20orf17|OVC10-2|TSH2|ZABC2|ZNF218 | |
| Cytomap | 22q12.2 | 20q13.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | myotubularin-related protein 3FYVE (Fab1 YGLO23 Vsp27 EEA1 domain) dual-specificity protein phosphataseFYVE domain-containing dual specificity protein phosphatase 1phosphatidylinositol-3,5-bisphosphate 3-phosphatasephosphatidylinositol-3-phosphate pho | teashirt homolog 2cell growth-inhibiting protein 7ovarian cancer-related protein 10-2serologically defined colon cancer antigen 33 liketeashirt family zinc finger 2zinc finger protein 218 | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q13615 | Q9NRE2 | |
| Ensembl transtripts involved in fusion gene | ENST00000401950, ENST00000333027, ENST00000323630, ENST00000351488, ENST00000406629, ENST00000415511, | ENST00000371497, ENST00000603338, ENST00000329613, | |
| Fusion gene scores | * DoF score | 12 X 5 X 9=540 | 22 X 6 X 8=1056 |
| # samples | 15 | 26 | |
| ** MAII score | log2(15/540*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(26/1056*10)=-2.02202630633 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: MTMR3 [Title/Abstract] AND TSHZ2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | MTMR3 | GO:0006470 | protein dephosphorylation | 10733931 |
| Hgene | MTMR3 | GO:0046856 | phosphatidylinositol dephosphorylation | 10900271|11676921 |
| Hgene | MTMR3 | GO:0060304 | regulation of phosphatidylinositol dephosphorylation | 16787938 |
| Hgene | MTMR3 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process | 11676921 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | LIHC | TCGA-EP-A2KA-01A | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-3UTR | ENST00000401950 | ENST00000371497 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-3UTR | ENST00000401950 | ENST00000603338 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-intron | ENST00000401950 | ENST00000329613 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-3UTR | ENST00000333027 | ENST00000371497 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-3UTR | ENST00000333027 | ENST00000603338 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-intron | ENST00000333027 | ENST00000329613 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-3UTR | ENST00000323630 | ENST00000371497 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-3UTR | ENST00000323630 | ENST00000603338 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-intron | ENST00000323630 | ENST00000329613 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-3UTR | ENST00000351488 | ENST00000371497 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-3UTR | ENST00000351488 | ENST00000603338 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 5UTR-intron | ENST00000351488 | ENST00000329613 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| intron-3UTR | ENST00000406629 | ENST00000371497 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| intron-3UTR | ENST00000406629 | ENST00000603338 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| intron-intron | ENST00000406629 | ENST00000329613 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 3UTR-3UTR | ENST00000415511 | ENST00000371497 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 3UTR-3UTR | ENST00000415511 | ENST00000603338 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
| 3UTR-intron | ENST00000415511 | ENST00000329613 | MTMR3 | chr22 | 30279348 | + | TSHZ2 | chr20 | 52103683 | + |
Top |
FusionProtFeatures for MTMR3_TSHZ2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MTMR3 | TSHZ2 |
| Phosphatase that acts on lipids with a phosphoinositolheadgroup. Has phosphatase activity towards phosphatidylinositol3-phosphate and phosphatidylinositol 3,5-bisphosphate. May alsodephosphorylate proteins phosphorylated on Ser, Thr, and Tyrresidues (PubMed:10733931). {ECO:0000269|PubMed:10733931,ECO:0000269|PubMed:11676921}. | Probable transcriptional regulator involved indevelopmental processes. May act as a transcriptional repressor(Potential). {ECO:0000305}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MTMR3_TSHZ2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MTMR3_TSHZ2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| MTMR3 | CUL3, HIVEP1, ANKRD28, PNO1, WRAP73, AURKA, HERC2, ATM, THOC2, MTOR, MTMR4, MLST8, RPTOR, PLK1, EYA3, MTMR3, ORC4, HEATR1, MAPK1IP1L, IPO5, SSBP1, NUP205, MED18, ALOX5, HDAC11, TULP3, DNAJC10, FGFR2, TRIM25 | TSHZ2 | APBB1, PYCARD, UBE2I |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MTMR3_TSHZ2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MTMR3_TSHZ2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|